Evaluation of Neurotoxicity With Human Pluripotent Stem Cell–Derived Cerebral Organoids

Author:

Parmentier Thomas12,LaMarre Jonathan1,Lalonde Jasmin3

Affiliation:

1. Department of Biomedical Sciences, Ontario Veterinary College University of Guelph Guelph Ontario Canada

2. Current address: Département de Sciences Cliniques, Faculté de Médecine Vétérinaire Université de Montréal Saint‐Hyacinthe Québec Canada

3. Department of Molecular and Cellular Biology, College of Biological Science University of Guelph Guelph Ontario Canada

Abstract

AbstractThe recent development of human cerebral organoids provides an invaluable in vitro model of human brain development to assess the toxicity of natural or man‐made toxic substances. By recapitulating key aspects of early human neurodevelopment, investigators can evaluate with this three‐dimensional (3D) model the effect of certain compounds on the formation of neuronal networks and their electrophysiological properties with more physiological relevance than neurons grown in monolayers and in cultures composed of a unique cell type. This promising potential has contributed to the development of a large number of diverse protocols to generate human cerebral organoids, making interlaboratory comparisons of results difficult. Based on a previously published protocol to generate human cortical organoids (herein called cerebral organoids), we detail several approaches to evaluate the effect of chemicals on neurogenesis, apoptosis, and neuronal function when exogenously applied to cultured specimens. Here, we take as an example 4‐aminopyridine, a potassium channel blocker that modulates the activity of neurons and neurogenesis, and describe a simple and cost‐effective way to test the impact of this agent on cerebral organoids derived from human induced pluripotent stem cells. We also provide tested protocols to evaluate neurogenesis in cerebral organoids with ethynyl deoxyuridine labeling and neuronal activity with live calcium imaging and microelectrode arrays. Together, these protocols should facilitate the implementation of cerebral organoid technologies in laboratories wishing to evaluate the effects of specific compounds or conditions on the development and function of human neurons with only basic cell culture equipment. © 2023 The Authors. Current Protocols published by Wiley Periodicals LLC.Basic Protocol 1: Generation of human cerebral organoids from pluripotent stem cellsSupport Protocol 1: Human pluripotent stem cell cultureBasic Protocol 2: Evaluation of neurogenesis in cerebral organoids with ethynyl deoxyuridine labelingBasic Protocol 3: Calcium imaging in cerebral organoidsBasic Protocol 4: Electrophysiological evaluation of cerebral organoids with microelectrode arraysSupport Protocol 2: Immunostaining of cerebral organoids

Publisher

Wiley

Subject

Medical Laboratory Technology,Health Informatics,General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Neuroscience

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3